---
title: "XUERONG: The shareholding ratio of the controlling shareholder and its concerted actors has decreased to 20.8842%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255769546.md"
description: "XUERONG announced that the company's controlling shareholder, Mr. Yang Yongping, and his concerted party, Zhejiang Yinwan Private Fund Management Co., Ltd. - Yinwan Huayi No. 1 Private Securities Investment Fund, saw their shareholding ratio decrease from 21.1404% to 20.8842%. This change is due to the conversion of the company's convertible bonds into shares, which increased the total share capital of the company and led to a passive dilution of their shareholding ratio. This change in equity does not involve the controlling shareholder and his concerted party reducing their holdings in the company"
datetime: "2025-09-03T11:07:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255769546.md)
  - [en](https://longbridge.com/en/news/255769546.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255769546.md)
---

# XUERONG: The shareholding ratio of the controlling shareholder and its concerted actors has decreased to 20.8842%

XUERONG announced that the company's controlling shareholder, Mr. Yang Yongping, and his concerted party, Zhejiang Yinwan Private Fund Management Co., Ltd. - Yinwan Huayi No. 1 Private Securities Investment Fund, saw their shareholding ratio decrease from 21.1404% to 20.8842%. This change is due to the conversion of the company's convertible bonds into shares, which increased the total share capital of the company, resulting in a passive dilution of their shareholding ratio. This change in equity does not involve the controlling shareholder and his concerted party reducing their holdings in the company

### Related Stocks

- [300511.CN](https://longbridge.com/en/quote/300511.CN.md)

## Related News & Research

- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [08:59 ETPurina Institute Drives the Conversation on Microbiome Innovation in Veterinary Medicine](https://longbridge.com/en/news/286917434.md)